Your Life on High Dose Steroids

Last Modified: October 3, 2003

Share article


Conference Dates: Wednesday, December 17, 2003
Conference Location: Penn Tower Hotel, Bridge Level Conference Room


Sponsoring Group: Abramson Cancer Center/Leukemia-Lymphoma Society

Conference Objectives: Patient Education

Who Should Attend: Patients, families, caregivers

Conference Agenda:

Edward A. Stadtmauer, M.D.
Associate Professor of Medicine
Director, Bone Marrow & Stem Cell Transplantation Program Director, Hematologic Malignancies Program "The Use of High Dose Steroids in treating cancer"

Patricia Mangan, MSN, CRNP
Coordinator, Bone Marrow & Stem Cell Transplantation Program

Registration Information: Jill Harrington LaMorie, MSW, LSW, Patient Services Coordinator, 215-349-8869

Conference Fees: None

Continuing Education: No


News
Corticorelin Acetate Has Steroid-Sparing Effect in Brain Cancer

Feb 8, 2013 - Corticorelin acetate administration to patients with peritumoral brain edema allows the reduction of steroid doses and is associated with reduced incidence and severity of steroid-induced myopathy and other steroid-related adverse effects, according to research published online Feb. 4 in the Journal of Clinical Oncology.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More



OncoLink Cancer Treatment and Resources